Down-regulation of a panel of immune-related lncRNAs in breast cancer

Soudeh Ghafouri-Fard1, Mohammad Asadi2, Behnoush Sohrabi3

  • 1Department of Medical Genetics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Insights

This study investigated nine immune-related long non-coding RNAs (lncRNAs) in breast cancer. Six lncRNAs were found to be downregulated in tumor tissues, suggesting their potential as novel biomarkers for breast cancer detection.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Breast cancer is a prevalent malignancy in women, with long non-coding RNAs (lncRNAs) playing an increasingly recognized role in its pathogenesis.
  • Immune-related lncRNAs are crucial in cancer development, but some remain under-investigated in breast cancer.
  • Understanding the expression patterns of specific lncRNAs can offer insights into tumor immunity and progression.

Purpose of the Study:

  • To compare the expression levels of nine selected immune-related lncRNAs between breast cancer tissues and paired non-cancerous tissues.
  • To evaluate the potential of these lncRNAs as diagnostic biomarkers for breast cancer.
  • To explore the association between the expression of these lncRNAs and clinical characteristics of breast cancer patients.

Main Methods:

  • Gene expression analysis was performed on paired breast cancer and adjacent non-cancerous tissue samples.
  • Quantitative real-time PCR or similar expression assay was used to measure the levels of nine specific immune-related lncRNAs.
  • Statistical analyses, including differential expression analysis and receiver operating characteristic (ROC) curve analysis, were conducted to assess significance and diagnostic performance.

Main Results:

  • Six of the nine investigated lncRNAs (lnc-MICAL3-2, lnc-DDX31, LINC01063, LINC02381, ENST0000615051, and lnc-TRIM43B-1) showed significantly decreased expression in breast cancer samples compared to control tissues.
  • The expression levels of these downregulated lncRNAs were found to correlate with various clinical features of breast cancer.
  • Lnc-TRIM43B-1 demonstrated high accuracy in differentiating between tumor and non-tumor tissues, with an AUC of 0.82, sensitivity of 76%, and specificity of 73.24%.

Conclusions:

  • The identified downregulated immune-related lncRNAs may serve as potential tissue biomarkers for breast cancer diagnosis.
  • These lncRNAs' ability to distinguish between tumoral and non-tumoral tissues highlights their clinical relevance.
  • Further research into the functional roles of these lncRNAs in breast cancer immunity and progression is warranted.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.2K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
22.6K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.4K
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
9.6K